Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 13.6B | 13.2B | 13.3B | 12.9B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 2.8B | 3.7B | 3.6B | 3.6B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 4.6B | 4.6B | 4.4B | 3.9B |
| Tax provision | 1.2B | 1.2B | 1.2B | 1.0B |
| Net income | 3.4B | 3.4B | 3.2B | 2.9B |
| Basic EPS | — | 1.3 | 1.2 | 1.1 |
| Diluted EPS | — | 1.3 | 1.2 | 1.1 |
| Basic average shares | — | 2.6B | 2.6B | 2.6B |
| Diluted average shares | — | 2.6B | 2.6B | 2.6B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |